Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College Of Radiology 95-09

Journal of Clinical Oncology

Volumn 28, Issue 7, 2010, Pages 1106-1111

  Zietman, Anthony L ^a   Bae, Kyounghwa ^a   Slater, Jerry D ^a   Shipley, William U ^a   Efstathiou, Jason A ^a   Coen, John J ^a   Bush, David A ^a   Lunt, Margie ^a   Spiegel, Daphna Y ^a   Skowronski, Rafi ^a   Rodney Jabola, B ^a   Rossi, Carl J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMISTRY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; EARLY CANCER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAZARD RATIO; HUMAN; HYPOTHESIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; ADENOCARCINOMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSTATE TUMOR;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 77949509341     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.8475     Document Type: Article

References (25)

1. Cooperberg MR, Broering JM, Litwin MS, et al: The contemporary management of prostate cancer in the United States: Lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 171: 1393-1401, 2004 (Pubitemid 38365382)
2. Kupelian PA, Potters L, Khuntia D, et al: Radical prostatectomy, external beam radiotherapy < 72G y or > 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25-33, 2004 (Pubitemid 38010333)
3. Zietman AL, Chung CS, Coen JJ, et al: 10-year outcome for men with localized prostate cancer treated with external radiation therapy: Results of a cohort study. J Urol 171:210-214, 2004 (Pubitemid 37549125)
4. Dearnaley DP, Sydes M, Graham JD, et al: Escalated dose versus standard dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol 8:475-487, 2007 (Pubitemid 46805903)
5. Al-Mamgani A, van Putten WLJ, Heemsbergen WD, et al: Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72:980-988, 2008
6. Kuban DA, Tucker SL, Dong L, et al: Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67-74, 2008 (Pubitemid 350251041)
7. Zietman AL, Desilvio ML, Slater JD, et al: Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. A randomized controlled trial. JAMA 294:1233-1239, 2005 [Erratum: JAMA 299:899-900, 2008]
8. Vicini FA, Kestin LL, Martinez AA: The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 45:553-561, 1999 (Pubitemid 29462632)
9. Gardner BG, Zietman AL, Shipley WU, et al: Late normal tissue sequelae in the second decade following high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167:123-126, 2002 (Pubitemid 34024514)
10. Shipley WU, Tepper JE, Pront GR, et al: Proton radiation as boost therapy for localized prostatic carcinoma. JAMA 241:1912-1915, 1979
11. Shipley WU, Verhey LJ, Munzenrider JE, et al: Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 32:3-12, 1995
12. Dugan TC, Shipley WU, Young RH, et al: Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: Correlation with original histologic grade and current PSA levels. J Urol 146:1313-1316, 1991
13. Slater JD, Yonemoto LT, Rossi CJ, et al: Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 42:299-304, 1998 (Pubitemid 28502775)
14. American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiotherapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
15. Roach M, Hanks G, Thames H, et al: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965-974, 2006
16. Lawton CA, Won M, Pilepich M: Long-term treatment sequelae following external beam radiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21:935-939, 1991
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:447-457, 1958
18. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
19. Kim K, Tsiatis AA: Study duration for clinical trials with survival response and early stopping rule. Biometrics 46:81-92, 1990 (Pubitemid 20245608)
20. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1143, 1988
21. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
22. Fine J, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
23. D'Amico AV, Chen MH, Oh-Ung J, et al: Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the PSA-era. Int J Radiat Oncol Biol Phys 54:436-441, 2002 (Pubitemid 35286809)
24. Crook JM, Bahadur YA, Robertson S: Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 79:81-89, 1997 (Pubitemid 26425511)
25. Talcott J, Zietman A, Rossi C, et al: Long-term quality of life after conventional-dose versus high-dose radiation for prostate cancer: Results from a randomized trial PROG 9509. J Clin Oncol 26:264s, 2008 (suppl; abstr 5058)